"Fever" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An abnormal elevation of body temperature, usually as a result of a pathologic process.
| Descriptor ID |
D005334
|
| MeSH Number(s) |
C23.888.119.344
|
| Concept/Terms |
Fever- Fever
- Fevers
- Pyrexia
- Pyrexias
- Hyperthermia
- Hyperthermias
|
Below are MeSH descriptors whose meaning is more general than "Fever".
Below are MeSH descriptors whose meaning is more specific than "Fever".
This graph shows the total number of publications written about "Fever" by people in this website by year, and whether "Fever" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 1 | 0 | 1 |
| 2001 | 0 | 1 | 1 |
| 2002 | 1 | 0 | 1 |
| 2003 | 2 | 5 | 7 |
| 2004 | 1 | 2 | 3 |
| 2005 | 2 | 0 | 2 |
| 2006 | 0 | 3 | 3 |
| 2007 | 1 | 4 | 5 |
| 2008 | 2 | 3 | 5 |
| 2009 | 0 | 3 | 3 |
| 2010 | 1 | 3 | 4 |
| 2011 | 3 | 1 | 4 |
| 2012 | 1 | 1 | 2 |
| 2013 | 0 | 5 | 5 |
| 2014 | 3 | 4 | 7 |
| 2015 | 0 | 2 | 2 |
| 2016 | 2 | 7 | 9 |
| 2017 | 66 | 80 | 146 |
| 2018 | 49 | 78 | 127 |
| 2019 | 21 | 34 | 55 |
| 2020 | 41 | 157 | 198 |
| 2021 | 14 | 72 | 86 |
To return to the timeline, click here.
Below are the most recent publications written about "Fever" by people in Profiles.
-
Is carbonic anhydrase inhibition useful as a complementary therapy of Covid-19 infection? J Enzyme Inhib Med Chem. 2021 Dec; 36(1):1230-1235.
-
Symptoms Reported With New Onset of Loss of Taste or Smell in Individuals With and Without SARS-CoV-2 Infection. JAMA Otolaryngol Head Neck Surg. 2021 10 01; 147(10):911-914.
-
Impact of fever thresholds in detection of COVID-19 in Department of Veterans Affairs Community Living Center residents. J Am Geriatr Soc. 2021 11; 69(11):3044-3050.
-
Safety and antibody response after one and/or two doses of BNT162b2 Anti-SARS-CoV-2 mRNA vaccine in patients treated by CAR T cells therapy. Br J Haematol. 2022 01; 196(2):360-362.
-
Clinical and laboratory factors associated with coronavirus disease 2019 (Covid-19): A systematic review and meta-analysis. Rev Med Virol. 2021 11; 31(6):e2288.
-
Ischemic Lesions in the Brain of a Neonate With SARS-CoV-2 Infection. Pediatr Infect Dis J. 2021 09 01; 40(9):e340-e343.
-
20-Year-old female with fever, cough, and dyspnea: Acute lupus pneumonitis during the pandemic of coronavirus disease 2019 (COVID-19). Lupus. 2021 Oct; 30(11):1856-1862.
-
Case Report of Severe COVID-19 Pneumonia in a Term Newborn. J Trop Pediatr. 2021 08 27; 67(4).
-
Persisting symptoms three to eight months after non-hospitalized COVID-19, a prospective cohort study. PLoS One. 2021; 16(8):e0256142.
-
Initial experience of the safety and tolerability of the BNT162b2 (Pfizer-Bio-N-Tech) vaccine in extremely vulnerable children aged 12-15 years. Arch Dis Child. 2022 02; 107(2):205-207.